Jonathan Hopper, M.D., serves as the Chief Medical Officer at VERICEL CORP, a leading biotechnology company specializing in advanced therapies for sports medicine and severe burn care. Dr. Hopper brings a wealth of experience and expertise to his role, having spent over two decades in the medical and pharmaceutical industries. Before joining VERICEL, he held several key positions, including Senior Vice President of Clinical Development at a prominent biopharma company, where he was instrumental in the development and approval of groundbreaking treatments for rare diseases. Dr. Hopper's academic background is equally impressive. He earned his medical degree from a top-tier medical school and completed his residency in internal medicine at a renowned teaching hospital. His commitment to advancing medical science is evident in his numerous publications in peer-reviewed journals and his active participation in professional medical associations. At VERICEL, Dr. Hopper leads the clinical development and medical affairs teams, overseeing the design and execution of clinical trials for the company's innovative cell therapy products. His strategic vision and leadership have been pivotal in driving VERICEL's mission to deliver life-changing therapies to patients. In addition to his professional accomplishments, Dr. Hopper is known for his dedication to mentoring young physicians and scientists. He frequently speaks at medical conferences and contributes to educational programs aimed at fostering the next generation of medical professionals. Under his guidance, VERICEL continues to make significant strides in the field of regenerative medicine, solidifying its position as a leader in the industry.